Lv1
28 积分 2026-06-11 加入
Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study
8小时前
求助中
Sheng Mai Yin shows anti-fatigue, anti-hypoxia and cardioprotective potential in an experimental joint model of fatigue and acute myocardial infarction
1个月前
已完结
Exploring the effective components and mechanism of Shengmaiyin (Dangshen Prescription) on the treatment of chronic heart failure based on chinmedomics strategy
2个月前
已完结
Efficacy and Safety of Shengmai Preparation Combined with Western Medicine for Coronary Heart Disease: A Systematic Review and Meta-Analysis
2个月前
已完结
皖公网安备34019202002308
